Your browser doesn't support javascript.
loading
Assessing treatment response to oral drugs for multiple sclerosis in real-world setting: a MAGNIMS Study.
Ruggieri, Serena; Prosperini, Luca; Al-Araji, Sarmad; Annovazzi, Pietro Osvaldo; Bisecco, Alvino; Ciccarelli, Olga; De Stefano, Nicola; Filippi, Massimo; Fleischer, Vinzenz; Evangelou, Nikos; Enzinger, Christian; Gallo, Antonio; Garjani, Afagh; Groppa, Sergiu; Haggiag, Shalom; Khalil, Michael; Lucchini, Matteo; Mirabella, Massimiliano; Montalban, Xavier; Pozzilli, Carlo; Preziosa, Paolo; Río, Jordi; Rocca, Maria A; Rovira, Alex; Stromillo, Maria L; Zaffaroni, Mauro; Tortorella, Carla; Gasperini, Claudio.
Afiliação
  • Ruggieri S; Department of Neurosciences, San Camillo Forlanini Hospital, Rome, Italy.
  • Prosperini L; Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy.
  • Al-Araji S; Department of Neurosciences, San Camillo Forlanini Hospital, Rome, Italy.
  • Annovazzi PO; Department of Neuroinflammation, Queen Square MS Centre, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK.
  • Bisecco A; Neuroimmunology Unit-Multiple Sclerosis Center, Hospital of Gallarate, ASST della Valle Olona, Gallarate, Italy.
  • Ciccarelli O; Department of Advanced Medical and Surgical Sciences, University of Campania 'Luigi Vanvitelli', Naples, Italy.
  • De Stefano N; Department of Neuroinflammation, Queen Square MS Centre, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK.
  • Filippi M; National Institute for Health Research Biomedical Research Centre, University College London Hospitals, London, UK.
  • Fleischer V; Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy.
  • Evangelou N; Neurology Unit and Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Enzinger C; Vita-Salute San Raffaele University, Milan, Italy.
  • Gallo A; Department of Neurology and Neuroimaging Center (NIC) of the Focus Program Translational Neuroscience (FTN), University Medical Center of the Johannes Gutenberg University, Mainz, Germany.
  • Garjani A; Mental Health & Clinical Neuroscience Unit, University of Nottingham, Nottingham, UK.
  • Groppa S; Department of Neurology, Nottingham University Hospitals NHS Trust, Nottingham, UK.
  • Haggiag S; Department of Neurology, Medical University of Graz, Graz, Austria.
  • Khalil M; Department of Radiology (Division of Neuroradiology, Vascular and Interventional Radiology), Medical University of Graz, Graz, Austria.
  • Lucchini M; Department of Advanced Medical and Surgical Sciences, University of Campania 'Luigi Vanvitelli', Naples, Italy.
  • Mirabella M; Mental Health & Clinical Neuroscience Unit, University of Nottingham, Nottingham, UK.
  • Montalban X; Department of Neurology, Nottingham University Hospitals NHS Trust, Nottingham, UK.
  • Pozzilli C; Department of Neurology and Neuroimaging Center (NIC) of the Focus Program Translational Neuroscience (FTN), University Medical Center of the Johannes Gutenberg University, Mainz, Germany.
  • Preziosa P; Department of Neurosciences, San Camillo Forlanini Hospital, Rome, Italy.
  • Río J; Department of Neurology, Medical University of Graz, Graz, Austria.
  • Rocca MA; Multiple Sclerosis Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
  • Rovira A; Centro di ricerca Sclerosi Multipla (CERSM), Università Cattolica del Sacro Cuore, Rome, Italy.
  • Stromillo ML; Multiple Sclerosis Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
  • Zaffaroni M; Centro di ricerca Sclerosi Multipla (CERSM), Università Cattolica del Sacro Cuore, Rome, Italy.
  • Tortorella C; Centre d'Esclerosi Multiple de Catalunya (Cemcat), Department of Neurology/Neuroimmunology, Hospital Universitari Vall d'Hebron, Universitat Autonoma de Barcelona, Barcelona, Spain.
  • Gasperini C; Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy.
J Neurol Neurosurg Psychiatry ; 95(2): 142-150, 2024 Jan 11.
Article em En | MEDLINE | ID: mdl-37775266
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Recidivante-Remitente / Esclerose Múltipla Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: J Neurol Neurosurg Psychiatry Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Itália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Recidivante-Remitente / Esclerose Múltipla Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: J Neurol Neurosurg Psychiatry Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Itália